Mon / May 6th
by
According to a new study compiled by UK researchers, psilocybin — the naturally occurring psychedelic in so-called “magic mushrooms” — shows promise as an effective treatment for depression.
Full story after the jump.
a word from our sponsors:
become a sponsor
advertisement
advertise here
A recent study in the United Kingdom found that psilocybin, the naturally occurring psychedelic compound in hallucinogenic (or “magic”) mushrooms, is an effective treatment for depression.
Researchers behind the study found that psilocybin outperformed niacin (or Vitamin B), microdoses of other psychedelics, and a placebo in the treatment of depression symptoms, according to a Medical News Today report.
The peer-reviewed research, published in The BMJ, represents a systemic review and meta-analysis of past studies. Researchers utilized seven randomized controlled trials that included studies comparing psilocybin’s efficacy as a depression treatment to other substances, and studies utilizing psychotherapy under both the experimental and control conditions so that psilocybin’s effects could be distinguished from those of psychotherapy, the report said.
The report’s authors called for more research into the subject before considering or enacting changes at the clinical level.
Dr. Akanksha Sharma — a neurologist, neuro-oncologist, and palliative medicine practitioner at Pacific Neuroscience Institute in Santa Monica, California — told Medical News Today that psychedelics like psilocybin can re-wire the brain’s response to stress and negative emotions, but that scientists do not fully understand the process.
“At this point, we know that altered states of consciousness can help patients face and process difficult emotions associated with their mental health condition or disease. In this state with the right guides, we can potentially reframe and accept our condition or find peace.” — Dr. Sharma, in the report
Meanwhile, according to research published last year in the journal Psychedelic Medicine, a majority of American Psychiatric Association members believe that hallucinogens show promise in treating psychiatric conditions.
Get daily cannabis business news updates. Subscribe
Have an additional perspective to share? Send us a message to let us know, and if your comment is chosen by our editors it could be featured here.
Note: our editors approve comments that provide new and succinct insight to our audience. If your comment is chosen for publishing, it will appear at the end of the article along with your name, job title, and organization. If you have a profile in the Ganjapreneur Business Index, your comment will also include a backlink for reference. If you are suggesting a correction, we will look into the issue further.
End
Authored By:
Based in Portland, Oregon, Graham is Ganjapreneur’s Chief Editor. He has been writing about the legalization landscape since 2012 and has been contributing to Ganjapreneur since our official launch in 2014.
a word from our sponsors:
become a sponsor
a word from our sponsors:
become a sponsor
advertisement
advertise here
Mon / May 6th
Fri / May 3rd
Fri / May 3rd
Wed / May 1st
Wed / May 1st
Wed / May 1st
View all news Get email updates
Create a profile View all categories
Angela Schweers
Kyle Loucks
AROYA
a word from our sponsors:
become a sponsor
advertisement
advertise here
Esssential cannabis industry news & insights, delivered daily.
Trusted cannabis business intelligence.
Copyright 2024 © Ganjapreneur.com // All rights reserved. // Terms of Use // Advertising Policy // Privacy Policy
DISCLAIMER: Ganjapreneur.com is intended as an educational resource for law-abiding professionals and those who are curious about entrepreneurial and/or investment opportunities in emerging markets. We do not offer investment advice, and we encourage all visitors and readers to do their own due dilligence before investing in any of the companies or markets that we write about. Be advised that possessing, using, distributing and selling cannabis are all federal crimes in the United States of America and the articles, pages, links, and other types of information on this site are not intended to assist you in violating federal law. Ganjapreneur.com and all associated entities and individuals are not responsible for third party content and/or links published on this website.
Website & branding by the Ganjapreneur in-house agency:
Uplifted cannabis industry branding & marketing.